A randomized trial tested whether renal resistive index (RRI) can refine blood pressure targets in sepsis care, with investigators reporting an approach designed to individualize mean arterial pressure (MAP) based on kidney hemodynamics. Published in Nature Communications, the study compared RRI-guided MAP adjustment against standard care targets in critically ill patients. The premise is that Doppler-derived kidney flow physiology may better capture organ-level needs than uniform MAP cutoffs, supporting a more physiologic approach to titrating perfusion. The trial’s randomized design aims to reduce confounding associated with observational sepsis studies and bring hemodynamic personalization closer to bedside use. If validated in broader settings, RRI-guided strategies could change how ICUs operationalize “adequate” perfusion goals in sepsis, where balancing under-resuscitation risk and overtreatment harms remains central to outcomes.